Recent research indicates that 4FMA, a synthetic copyright compound, might hold promising potential for therapeutic applications. While still in its developmental phase, studies have demonstrated that 4FMA can evoke intense copyright experiences, possibly rivaling those of more established psychedelics like LSD and copyright. Researchers are curre